India likely to get COVID-19 vaccine approved for emergency use before December ends: Report MD Bureau24 Dec 2020 1:00 PM ISTThe sources said that the Pune-based SII's vaccine candidate has an edge over Pfizer's because of its low cost, effective logistics and easy storage.
Bharat Biotech re-applies with DCGI for emergency approval of Covaxin MD Bureau24 Dec 2020 10:30 AM ISTNew Delhi: Hyderabad-based Bharat Biotech, which is developing the country's indigenous coronavirus vaccine in collaboration with the Indian Council...
AstraZeneca COVID-19 vaccine likely to get emergency nod by next week in India: Report Ruchika Sharma23 Dec 2020 3:11 PM ISTThe Indian regulator is only considering the two full-dose regimen of the shot despite it showing a lower success rate, the sources said.
Covaxin: Bharat Biotech recruits 13000 volunteers for Phase 3 trials Ruchika Sharma23 Dec 2020 1:10 PM ISTThe indigenously developed COVID-19 vaccine has been developed in collaboration with the Indian Council of Medical Research (ICMR) - National...
Pfizer, BioNTech COVID vaccine gets EU regulatory nod, inoculation to start from Dec 27 Ruchika Sharma22 Dec 2020 2:00 PM ISTAmsterdam: Europe's medicines regulator on Monday approved the use of the Covid-19 vaccine developed by U.S. company Pfizer and its German partner...
Takeda Pharma Chief asks transparency in virus vaccine rollout Ruchika Sharma21 Dec 2020 1:52 PM ISTTokyo: Pharmaceutical firms must be "very transparent" about the risks and benefits of vaccines in efforts to end the coronavirus pandemic, the head...
Adar Poonawalla says govt need to indemnify vaccine makers against all lawsuits Ruchika Sharma21 Dec 2020 1:29 PM ISTNew Delhi: Vaccine manufacturers need to have protection against all lawsuits for their vaccines especially during a pandemic, Serum Institute of...
India needs Rs 80,000 crore for COVID-19 vaccine distribution in 2021: Serum Institute of India MD Bureau20 Dec 2020 10:15 AM ISTDr. Satish D. Ravetkar added that India would further have to ensure adequate power supply that could help maintain the temperature required to keep...
JnJ enrolls about 45,000 participants for COVID vaccine late-stage trial Ruchika Sharma20 Dec 2020 9:15 AM ISTJ&J said it plans to submit an emergency use authorization application to the USFDA in February if the data from the study is safe and effective.
Pfizer applies for Japenese approval for COVID vaccine Ruchika Sharma20 Dec 2020 9:00 AM ISTTokyo: Drugmaker Pfizer Inc said on Friday it had applied for approval in Japan for its COVID-19 vaccine, which is already being administered in the...
Moderna Covid-19 vaccine gets USFDA nod for emergency use amid pandemic surge MD Bureau19 Dec 2020 12:00 PM ISTOngoing studies of the Moderna two-shot vaccine show more than 94 percent effectiveness and strong protection among older adults.
COVID vaccine shows better immune response with two-dose regime: Oxford Ruchika Sharma19 Dec 2020 9:15 AM ISTLondon: Oxford's Covid-19 vaccine candidate has a better immune response when a two full-dose regime is used rather than a full-dose followed by a...
